glp-1 and macular degeneration We found that receptor agonists were associated with a lower risk of age-related (especially dry AMD) in adults with diabetes obesity compared with metformin or other weight-loss medications. # A recent study found that
Description
In a late-stage trial, an investigational GLP-1 pill from Eli Lilly helped diabetes patients lower their blood sugar and weight more than an oral version of Ozempic.
This plan is backed by the scientist, Ben Bikman, who studies insulin resistance, weight loss, and why people get sick

Tom White offers an example options trade for Eli Lilly.

Researchers tested liraglutide in stress models

Ro is a healthcare company connecting patients with US-licensed professionals all online

/PRNewswire/ -- Ro, the leading direct-to-patient healthcare company, today announced eligible patients can now access Foundayo (orforglipron) Eli Lilly...